| Dr Joseph Banno, MD | |
|
7309 N Knoxville Ave, Peoria, IL 61614-2085 | |
| (309) 692-9898 | |
| (309) 692-9055 |
| Full Name | Dr Joseph Banno |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 49 Years |
| Location | 7309 N Knoxville Ave, Peoria, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811951072 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 036053979 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Spoon River Home Hlth Services | Farmington, IL | Home health agency |
| Methodist Medical Center Of Illinois | Peoria, IL | Hospital |
| St Mary Medical Center | Galesburg, IL | Hospital |
| Saint Francis Medical Center | Peoria, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Urological Group Ltd | 3274434451 | 4 |
News Archive
Thanks to a new study of the retina, scientists at UC Santa Barbara have developed a greater understanding of how the nervous system becomes wired during early development.
Researchers at the Fisher Center for Alzheimer's Disease Research laboratory today published "Gamma-secretase Activating Protein is a Therapeutic Target for Alzheimer's Disease" in Nature online. Drs. Gen He (lead author) and Paul Greengard have discovered a protein that stimulates the production of beta-amyloid, and therefore represents a major new advance in Alzheimer's disease research.
New research finds improvements in access to care and health outcomes across racial and ethnic groups in Massachusetts since implementation of the state's health reform law in 2007 yet trends do not indicate progress in reducing disparities in the leading causes of illness and death, according to new research released today at the American Public Health Association's 141st Annual Meeting in Boston.
Janssen Research & Development, LLC has initiated the rolling submission of its Biologic License Application (BLA) for daratumumab to the U.S. Food and Drug Administration (FDA) for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent (IMiD), or who are double refractory to a PI and an IMiD.
At the American Society of Nephrology's Kidney Week 2011, Fresenius Medical Care, the world's largest provider of dialysis products and services, announced that it received U.S. Food and Drug Administration 510 (K) clearance to extend improved touch screen navigation on its most advanced hemodialysis delivery system, the 2008T.
› Verified 6 days ago
| Entity Name | Midwest Urological Group Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891715272 PECOS PAC ID: 3274434451 Enrollment ID: O20040120000463 |
News Archive
Thanks to a new study of the retina, scientists at UC Santa Barbara have developed a greater understanding of how the nervous system becomes wired during early development.
Researchers at the Fisher Center for Alzheimer's Disease Research laboratory today published "Gamma-secretase Activating Protein is a Therapeutic Target for Alzheimer's Disease" in Nature online. Drs. Gen He (lead author) and Paul Greengard have discovered a protein that stimulates the production of beta-amyloid, and therefore represents a major new advance in Alzheimer's disease research.
New research finds improvements in access to care and health outcomes across racial and ethnic groups in Massachusetts since implementation of the state's health reform law in 2007 yet trends do not indicate progress in reducing disparities in the leading causes of illness and death, according to new research released today at the American Public Health Association's 141st Annual Meeting in Boston.
Janssen Research & Development, LLC has initiated the rolling submission of its Biologic License Application (BLA) for daratumumab to the U.S. Food and Drug Administration (FDA) for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent (IMiD), or who are double refractory to a PI and an IMiD.
At the American Society of Nephrology's Kidney Week 2011, Fresenius Medical Care, the world's largest provider of dialysis products and services, announced that it received U.S. Food and Drug Administration 510 (K) clearance to extend improved touch screen navigation on its most advanced hemodialysis delivery system, the 2008T.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Banno, MD 7309 N Knoxville Ave, Peoria, IL 61614-2085 Ph: (309) 692-9898 | Dr Joseph Banno, MD 7309 N Knoxville Ave, Peoria, IL 61614-2085 Ph: (309) 692-9898 |
News Archive
Thanks to a new study of the retina, scientists at UC Santa Barbara have developed a greater understanding of how the nervous system becomes wired during early development.
Researchers at the Fisher Center for Alzheimer's Disease Research laboratory today published "Gamma-secretase Activating Protein is a Therapeutic Target for Alzheimer's Disease" in Nature online. Drs. Gen He (lead author) and Paul Greengard have discovered a protein that stimulates the production of beta-amyloid, and therefore represents a major new advance in Alzheimer's disease research.
New research finds improvements in access to care and health outcomes across racial and ethnic groups in Massachusetts since implementation of the state's health reform law in 2007 yet trends do not indicate progress in reducing disparities in the leading causes of illness and death, according to new research released today at the American Public Health Association's 141st Annual Meeting in Boston.
Janssen Research & Development, LLC has initiated the rolling submission of its Biologic License Application (BLA) for daratumumab to the U.S. Food and Drug Administration (FDA) for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent (IMiD), or who are double refractory to a PI and an IMiD.
At the American Society of Nephrology's Kidney Week 2011, Fresenius Medical Care, the world's largest provider of dialysis products and services, announced that it received U.S. Food and Drug Administration 510 (K) clearance to extend improved touch screen navigation on its most advanced hemodialysis delivery system, the 2008T.
› Verified 6 days ago
Jubilee Phan, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1001 Main St Ste 400, Peoria, IL 61606 Phone: 309-308-0920 Fax: 309-308-0930 | |
Dr. Robert Stuart, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 7309 N Knoxville Ave, Peoria, IL 61614 Phone: 309-692-9898 Fax: 309-692-9055 | |
Dr. James Nicholas Kenny Jr., M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 200 E Pennsylvania Ave, Suite 201, Peoria, IL 61603 Phone: 309-655-7700 Fax: 309-624-8790 | |
Dr. Churphena Reid, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1001 Main St, Suite 201, Peoria, IL 61606 Phone: 309-495-0282 Fax: 309-495-0298 | |
Dr. Giovanni Colombo, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 7309 N Knoxville Ave, Peoria, IL 61614 Phone: 309-692-9898 Fax: 309-692-9055 | |
Dr. Ted A Solomon, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 200 E Pennsylvania Ave, Suite 201, Peoria, IL 61603 Phone: 309-655-7700 Fax: 309-624-8790 | |
Dr. Jose M Hernandez, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 7309 N Knoxville Ave, Peoria, IL 61614 Phone: 309-692-9898 Fax: 309-692-9055 |